The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
Dai OgataLauren E HayduIsabella C GlitzaSapna Pradyuman PatelHussein A TawbiJennifer L McQuadeAdi DiabSuhendan EkmekciogluMichael K WongMichael A DaviesRodabe N AmariaPublished in: Cancer medicine (2021)
The ORR, PFS, and OS with anti-PD-1 therapy were poor in patients with AM and MM compared to those previously reported clinical trials for nonacral CM. High serum LDH was associated with significantly shorter OS.